Učitavanje...
A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab
Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3656669/ https://ncbi.nlm.nih.gov/pubmed/23687488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000351173 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|